Large-scale increases in P2X4, P2X5, TRPV1, and ASIC3 receptors in the DRG would potentially increase sensitivity to even low levels of these metabolites such that even activity as mild as upright posture and slow walking in CFS or CFS+FMS patients could produce sensations of fatigue and muscle pain that normal individuals would only feel during extreme activity [92]. The gene discussed is P2RX5; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.